Related Experiment Video
Updated: Jun 28, 2026

Apparatus for Harvesting Tissue Microcolumns
Published on: October 25, 2018
Percutaneous collagen induction: minimally invasive skin rejuvenation without risk of hyperpigmentation-fact or
Mathias C Aust1, Kerstin Reimers, Claudia Repenning
1Hannover, Germany; Zurich, Switzerland; and Graz, Austria From the Klinik für Plastische, Hand- und Wiederherstellungschirurgie, Medizinische Hochschule Hannover, the Department of Technical Chemistry, University of Hannover, the Klinik für Wiederherstellungschirurgie, Universitätsspital Zurich, and the Klinische Abteilung für Plastische, Rekonstruktive und Ästhetische Chirurgie, Universitätsklinik Graz.
Background:
Photoaging is generally treated by ablative procedures that injure the epidermis and basal membrane and lead to fibrosis of the papillary dermis. Damaging the epidermis significantly can cause potential adverse effects such as dyspigmentation. It was recently shown in clinical trials that percutaneous collagen induction therapy is an alternative for safely treating wrinkles and scars and for smoothening the skin without the risk of dyspigmentation.
Methods:
The purpose of this study was to increase current knowledge regarding whether percutaneous collagen induction therapy presents an effective means for skin rejuvenation without risk of dyspigmentation, as the authors' clinical data suggested. Fifty-six rats were assigned to three groups: group A (n = 24), percutaneous collagen induction therapy plus skin care; group B (n = 24), skin care; and group C (n = 8) controls. The authors evaluated the effect of percutaneous collagen induction therapy on the epidermis, melanocytes, and the pigmentation markers interleukin-10 and melanocyte-stimulating hormone.
Results:
Percutaneous collagen induction therapy left the epidermis intact without any damage to the stratum corneum, any other layers of the epidermis, or the basal membrane. No signs of dermabrasive reduction of epidermal thickness were evident 24 hours after the procedure. The number of melanocytes neither increased nor decreased in any of the groups. DNA microarray experiments demonstrated that interleukin-10 was increased in percutaneous collagen induction therapy-treated skin after 2 weeks. Concerning the MC1R (melanocyte-stimulating hormone) gene, gene expression microarray analysis indicated a faint down-regulation both 24 hours and 2 weeks after percutaneous collagen induction therapy.
Conclusion:
Percutaneous collagen induction therapy offers a modality with which to rejuvenate and improve skin appearance and quality without risk of dyspigmentation.
More Related Videos
03:47Enhancement of Facial Rejuvenation Through a Combination of 1565 nm Non-Ablative Fractional Laser with 30% Supramolecular Salicylic Acid
Published on: September 27, 2024
04:43Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
Published on: May 23, 2025
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Tissue Renewal without Stem Cells
However, failure of such a system...
Renewal of Skin Epidermal Stem Cells
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...